Author: Zhanel George G.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.32, Iss.9, 2009-09, pp. : 709-716
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical overview of the seizure risk of dalfampridine
By Haut Sheryl R. Bienen E. Jay Miller Aaron
Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. :
The therapeutic potential of inducing molecules
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. :
Tolerance-Inducing Immunosuppressive Strategies in Clinical Transplantation: An Overview
By Golshayan Dela Pascual Manuel
Drugs, Vol. 68, Iss. 15, 2008-01 ,pp. :